Fundraising Fox

Yvonne Yamanaka

Investor

Principal at venBio Partners · Board director at Eyconis

San Francisco, California

Writes $20M – $30M checks · typically $25M

About

Yvonne Yamanaka combines hands-on technical experience—she helped invent an immunotherapy platform as a graduate student and led its development at EMD/Merck Serono—and built companies from the whiteboard up at Flagship Pioneering.

Invests in

BiotechHealthtech

Board director at Eyconis

Intro paths

In turn, Yvonne can intro founders to Eyconis's investors below.

Experience

  1. venBio PartnersPartnercurrent2016 — presentSan Francisco Bay Area
  2. Flagship PioneeringAssociate2015 — 2016
  3. EMD Serono, Inc.Postdoctoral Fellow, Immuno-Oncology & Immuno-Technologies2014 — 2015
  4. Flagship PioneeringVentureLabs Fellow2014
  5. Massachusetts Institute of Technology (MIT)Ph.D., Biological Engineering2008 — 2014
  6. American Journal ExpertsContract Editor2012 — 2013

Colleagues at venBio Partners

Network2

Investors connected to Yvonne in public investor directories — a warm-intro map.

Frequently asked questions

Who is Yvonne Yamanaka?
Yvonne Yamanaka combines hands-on technical experience—she helped invent an immunotherapy platform as a graduate student and led its development at EMD/Merck Serono—and built companies from the whiteboard up at Flagship Pioneering.
Where does Yvonne Yamanaka work?
Yvonne Yamanaka is Principal at venBio Partners and Board director at Eyconis.
What does Yvonne Yamanaka invest in?
Yvonne Yamanaka invests in Biotech, Healthtech.
What check size does Yvonne Yamanaka write?
Yvonne Yamanaka typically writes checks of $20M – $30M.
Where did Yvonne Yamanaka go to school?
Yvonne Yamanaka studied at Massachusetts Institute of Technology (Doctor of Philosophy (Ph.D.), Biological Engineering); Duke University (B.S.E., Biomedical Engineering).

Same school

Shared employers